(RTTNews) - Solid Biosciences Inc. (SLDB) announced that it has received positive regulatory feedback from a recent Type C meeting with the U.S FDA, marking a key step forward for its gene therapy ...
When ice melts into water, it happens quickly, with the transition from solid to liquid being immediate. However, very thin materials do not adhere to these rules. Instead, an unusual state between ...
Roche has dropped five Chugai candidates from its clinical pipeline, echoing actions the Japanese business took earlier this year. Chugai revealed (PDF) the suspension of in-house development of the ...
Rezatapopt demonstrated a 33% overall response rate in tumors with TP53 Y220C mutations, with a median response duration of 6.2 months. The phase 2 PYNNACLE trial reported consistent safety results ...
To detect popular party drugs in human waste, researchers combined headspace solid-phase microextraction and solid-phase microextraction to detect these substances and their metabolites. South Korea ...
BOSTON--(BUSINESS WIRE)--Strand Therapeutics, a leader in next-generation mRNA-based therapeutics, today announced exciting preliminary Phase 1 clinical data for its lead investigational candidate, ...
Phase I multicenter, open-label, dose escalation study of T-1201, a small molecule drug conjugate, to assess safety, pharmacokinetics, and antitumor activity in advanced solid tumors. This is an ASCO ...
A recent article published in Nature Communications described a simultaneous solid-phase recycling and alloying method to address the limitations of traditional alloy recycling through melting. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results